Thomas Leggett

Chief Financial Officer, Stoke Therapeutics, Inc.

Bought, 12 months

$0.0M

Sold, 12 months

$0.1M

Companies

Latest trade

Mar 18, 2026

Companies

Stoke Therapeutics, Inc.Chief Financial Officer −$0.1M

Trades

STOK Sold 2,382 shares at $31.34 $0.1M Mar 18

STOK Sold 2,196 shares at $33.01 $0.1M Mar 17

Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.